In which type of constipation are stimulant laxatives contraindicated or should be avoided?

INI-CET EXAM -2026

Pharmacology

Medium

Appeared in: INI-CET EXAM -2026

Explanation

Spastic constipation, often associated with Irritable Bowel Syndrome (IBS), involves an over-sensitive colon with excessive, uncoordinated muscle contractions or spasms.
Stimulant laxatives (e.g., bisacodyl, senna) work by directly irritating the lining and nerve endings of the intestines to provoke peristalsis.
Using a stimulant laxative in a person with spastic constipation would aggravate the existing irritation and spasms, leading to increased abdominal pain and cramping.
Therefore, these laxatives are contraindicated or should be avoided in this condition, where the goal is to soothe the bowel, not stimulate it further.

Option B: Habitual constipation is primarily a functional issue related to lifestyle and behavior. While not the first-line treatment, stimulant laxatives are not contraindicated and can be used for short-term relief.
Option C: Atonic constipation is the opposite of spastic constipation. It is characterized by a 'lazy bowel' with poor muscle tone and weak peristalsis.
Option D: Post-operative constipation is common due to anesthesia, opioids, and immobility, which slow down the gut. Stimulant laxatives are frequently used in this setting to counteract these effects and promote the return of bowel function.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Pharmacology and Pathophysiology as background academic context rather than a clinical decision trigger.
A key nursing responsibility is to assess the patient's bowel habits and the potential cause of constipation before administering any laxative. Administering the wrong type can be ineffective or harmful.
Patient education is crucial. For spastic constipation, nurses should teach about stress management, avoiding trigger foods, and using bulk-forming agents or stool softeners instead of stimulants.
What if? If a patient with chronic pain develops constipation from long-term opioid use, this is known as Opioid-Induced Constipation (OIC). While stimulants might be used, more specific drugs like peripherally acting mu-opioid receptor antagonists (e.g., methylnaltrexone) are often more effective as they target the underlying cause without affecting pain relief.

How to Approach the Question

First, identify the key terms in the question: 'stimulant laxatives' and 'contraindicated' (or 'avoided').
Recall the mechanism of action for stimulant laxatives. They work by irritating the bowel to cause contractions.
Next, analyze the options, which are different types of constipation. Think about the pathophysiology of each type.
Ask yourself: In which of these conditions would adding an irritant be harmful?
Spastic constipation is defined by an already irritable, over-stimulated colon. Adding a stimulant would worsen the symptoms.
Atonic constipation is the opposite ('lazy bowel'), so a stimulant would be helpful. Habitual and post-operative are situations where stimulants are often used. This process leads to the correct answer.

Concept Tested & Keywords

Q7m9svjUNo6ZkfYR_alSvD

E6 Nutrition Kumud Khanna 2e p. 253-255

E6 Pharmacology Nursing Lilley 11e Part 3 p. 178-180